Yale-Gilead Partnership to Investigate Genetic, Molecular Basis of Cancer

Gilead is funding up to $100 million to the collaboration, which is aimed at identifying new molecular targets for the development of new cancer treatments.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories